MOVIPREP
Colon Cleansing
NorginePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Colon Cleansing cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ner1006 Norgine | Phase 3 | BB |
Trisulfate Norgine | Phase 3 | BB |
MACROGOLS Norgine | D |
Same molecule, other indications
MOVIPREP is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →